DK116870B - Analogifremgangsmåde til fremstilling af terapeutisk virksomme 11β,21-dihydroxy-3,20-dioxo- eller 21-hydroxy-3,11,20-trioxo-pregna-1,4-dien-(17α 16&alpha,-d)-2'metyloxazoliner eller 21-estere deraf. - Google Patents
Analogifremgangsmåde til fremstilling af terapeutisk virksomme 11β,21-dihydroxy-3,20-dioxo- eller 21-hydroxy-3,11,20-trioxo-pregna-1,4-dien-(17α 16&alpha,-d)-2'metyloxazoliner eller 21-estere deraf.Info
- Publication number
- DK116870B DK116870B DK204266AA DK204266A DK116870B DK 116870 B DK116870 B DK 116870B DK 204266A A DK204266A A DK 204266AA DK 204266 A DK204266 A DK 204266A DK 116870 B DK116870 B DK 116870B
- Authority
- DK
- Denmark
- Prior art keywords
- methyloxazolines
- pregna
- trioxo
- dioxo
- dihydroxy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
- C07J41/0027—Azides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
- C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
- C07J7/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
- C07J7/0025—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa substituted in position 16
- C07J7/0035—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa substituted in position 16 by a hydroxy group free esterified or etherified
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
- C07J71/001—Oxiranes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0036—Nitrogen-containing hetero ring
- C07J71/0057—Nitrogen and oxygen
- C07J71/0068—Nitrogen and oxygen at position 16(17)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Agricultural Machines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB17027/65A GB1077392A (en) | 1965-04-22 | 1965-04-22 | New steroids |
| GB3586565 | 1965-08-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK116870B true DK116870B (da) | 1970-02-23 |
Family
ID=26252388
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK204266AA DK116870B (da) | 1965-04-22 | 1966-04-21 | Analogifremgangsmåde til fremstilling af terapeutisk virksomme 11β,21-dihydroxy-3,20-dioxo- eller 21-hydroxy-3,11,20-trioxo-pregna-1,4-dien-(17α 16&alpha,-d)-2'metyloxazoliner eller 21-estere deraf. |
| DK204166AA DK117631B (da) | 1965-04-22 | 1966-04-21 | Fremgangsmåde til fremstilling af 20-oxopregnan-, 20-oxo-4-pregnen- eller 20-oxo-5(6)-pregnen-(17α, 16α-d)-oxazoliner. |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK204166AA DK117631B (da) | 1965-04-22 | 1966-04-21 | Fremgangsmåde til fremstilling af 20-oxopregnan-, 20-oxo-4-pregnen- eller 20-oxo-5(6)-pregnen-(17α, 16α-d)-oxazoliner. |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US3436389A (de) |
| AT (2) | AT260440B (de) |
| BE (2) | BE679821A (de) |
| BR (2) | BR6678805D0 (de) |
| CH (2) | CH471833A (de) |
| DE (3) | DE1568950A1 (de) |
| DK (2) | DK116870B (de) |
| ES (1) | ES325755A1 (de) |
| FI (2) | FI44905C (de) |
| FR (1) | FR5645M (de) |
| GB (1) | GB1077392A (de) |
| IL (2) | IL25494A (de) |
| NL (3) | NL6605174A (de) |
| NO (2) | NO127346B (de) |
| SE (2) | SE323675B (de) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1119081A (en) * | 1966-01-11 | 1968-07-10 | Lepetit Spa | New steroids |
| IT1141930B (it) * | 1980-04-28 | 1986-10-08 | Lepetit Spa | Esteri idrosolubili di steroido-ossazoli e loro composizioni farmaceutiche |
| IT1134455B (it) * | 1980-11-26 | 1986-08-13 | Lepetit Spa | Procedimento per la preparazione di derivati 16alfa-idrossi-17alfa-aminopregnanici |
| AR045536A1 (es) * | 2003-08-29 | 2005-11-02 | Ranbaxy Lab Ltd | Inhibidores de la fosfodiesterasa tipo -iv |
| EP1694655A2 (de) * | 2003-11-26 | 2006-08-30 | Ranbaxy Laboratories Limited | Phosphodiesteraseinhibitoren |
| US20080009535A1 (en) * | 2004-08-30 | 2008-01-10 | Sarala Balachandran | Inhibitors of phosphodiesterase type-IV |
| US7915286B2 (en) | 2005-09-16 | 2011-03-29 | Ranbaxy Laboratories Limited | Substituted pyrazolo [3,4-b] pyridines as phosphodiesterase inhibitors |
| EP1948167A1 (de) * | 2005-10-19 | 2008-07-30 | Ranbaxy Laboratories, Ltd. | Zusammensetzungen von phosphodiesterase-typ-iv-hemmern |
| US20090221664A1 (en) | 2005-10-19 | 2009-09-03 | Abhijit Ray | Pharmaceutical compositions of muscarinic receptor antagonists |
| CA2664247A1 (en) * | 2006-09-22 | 2008-03-27 | Ranbaxy Laboratories Limited | Inhibitors of phosphodiesterase type-iv |
| WO2008035316A2 (en) * | 2006-09-22 | 2008-03-27 | Ranbaxy Laboratories Limited | Phosphodiesterase inhibitors |
| CN101177443B (zh) * | 2006-11-09 | 2011-08-03 | 天津药业研究院有限公司 | 新的甾体化合物及其应用 |
| US20080207659A1 (en) * | 2007-02-15 | 2008-08-28 | Asit Kumar Chakraborti | Inhibitors of phosphodiesterase type 4 |
| MX2009009793A (es) * | 2007-03-14 | 2009-10-16 | Ranbaxy Lab Ltd | Derivados de pirazolo (3,4-b) piridina como inhibidores de fosfodiesterasa. |
| US20110130403A1 (en) * | 2007-03-14 | 2011-06-02 | Ranbaxy Laboratories Limited | Pyrazolo [3, 4-b] pyridine derivatives as phosphodiesterase inhibitors |
| EP2111861A1 (de) | 2008-04-21 | 2009-10-28 | Ranbaxy Laboratories Limited | Zusammensetzungen von Phosphodiesterase-IV-Hemmern |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2874154A (en) * | 1954-10-15 | 1959-02-17 | Syntex Sa | Process for the production of 20-keto-21-iodo steroids |
| US2923721A (en) * | 1955-12-13 | 1960-02-02 | Lab Francais Chimiotherapie | Method of preparing 3-keto delta1, 4 steroids |
| DE1223376B (de) * | 1963-12-14 | 1966-08-25 | Hoechst Ag | Verfahren zur Herstellung von 17alpha-Cyan-16alpha-hydroxy-steroiden der Pregnanreihe |
| US3349084A (en) * | 1965-05-17 | 1967-10-24 | Upjohn Co | Steroidal [16, 17-d]-2'-isoxazolines of the pregnane series |
-
0
- NL NL128816D patent/NL128816C/xx active
-
1965
- 1965-04-22 GB GB17027/65A patent/GB1077392A/en not_active Expired
-
1966
- 1966-03-30 US US538574A patent/US3436389A/en not_active Expired - Lifetime
- 1966-03-30 US US538555A patent/US3413286A/en not_active Expired - Lifetime
- 1966-03-30 IL IL25494A patent/IL25494A/xx unknown
- 1966-03-30 IL IL25493A patent/IL25493A/en unknown
- 1966-04-06 NO NO00162506A patent/NO127346B/no unknown
- 1966-04-15 NO NO00162597A patent/NO128152B/no unknown
- 1966-04-16 FI FI660985A patent/FI44905C/fi active
- 1966-04-16 FI FI660986A patent/FI44906C/fi active
- 1966-04-18 NL NL6605174A patent/NL6605174A/xx unknown
- 1966-04-18 BR BR178805/66A patent/BR6678805D0/pt unknown
- 1966-04-20 DE DE19661568950 patent/DE1568950A1/de active Pending
- 1966-04-20 DE DE1793662A patent/DE1793662C3/de not_active Expired
- 1966-04-21 DE DE19661568951 patent/DE1568951A1/de active Pending
- 1966-04-21 BE BE679821A patent/BE679821A/xx not_active IP Right Cessation
- 1966-04-21 ES ES0325755A patent/ES325755A1/es not_active Expired
- 1966-04-21 SE SE5444/66A patent/SE323675B/xx unknown
- 1966-04-21 DK DK204266AA patent/DK116870B/da unknown
- 1966-04-21 SE SE5443/66A patent/SE323674B/xx unknown
- 1966-04-21 NL NL6605375A patent/NL6605375A/xx unknown
- 1966-04-21 BE BE679820D patent/BE679820A/xx not_active IP Right Cessation
- 1966-04-21 DK DK204166AA patent/DK117631B/da unknown
- 1966-04-22 AT AT382766A patent/AT260440B/de active
- 1966-04-22 CH CH584666A patent/CH471833A/fr not_active IP Right Cessation
- 1966-04-22 AT AT382266A patent/AT265539B/de active
- 1966-04-22 CH CH584766A patent/CH453351A/fr unknown
- 1966-05-18 BR BR179615/66A patent/BR6679615D0/pt unknown
- 1966-07-20 FR FR70013A patent/FR5645M/fr not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| NO128152B (de) | 1973-10-08 |
| AT265539B (de) | 1968-10-10 |
| CH453351A (fr) | 1968-06-14 |
| DK117631B (da) | 1970-05-19 |
| GB1077392A (en) | 1967-07-26 |
| FI44906C (fi) | 1972-02-10 |
| IL25494A (en) | 1970-03-22 |
| IL25493A (en) | 1969-12-31 |
| SE323675B (de) | 1970-05-11 |
| DE1793662C3 (de) | 1973-11-08 |
| AT260440B (de) | 1968-03-11 |
| DE1568950A1 (de) | 1970-11-26 |
| DE1793662A1 (de) | 1972-08-03 |
| NL6605375A (de) | 1966-10-24 |
| SE323674B (de) | 1970-05-11 |
| FI44906B (de) | 1971-11-01 |
| DE1568951A1 (de) | 1970-06-18 |
| NL128816C (de) | |
| CH471833A (fr) | 1969-04-30 |
| ES325755A1 (es) | 1967-02-16 |
| NL6605174A (de) | 1966-10-24 |
| BR6679615D0 (pt) | 1973-10-23 |
| US3413286A (en) | 1968-11-26 |
| BE679820A (de) | 1966-10-03 |
| FR5645M (de) | 1967-12-26 |
| NO127346B (de) | 1973-06-12 |
| DE1793662B2 (de) | 1973-04-19 |
| BR6678805D0 (pt) | 1973-09-18 |
| BE679821A (de) | 1966-10-03 |
| FI44905B (de) | 1971-11-01 |
| FI44905C (fi) | 1972-02-10 |
| US3436389A (en) | 1969-04-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK116128B (da) | Fremgangsmåde til fremstilling af terapeutisk virksomme 17α-(alkanoyloxy eller cycloalkanoyloxy)-21-(alkanoyloxy eller cycloalkanoyloxy)-16β-methyl-9α-halogen-11β-hydroxy-Δ<1,4>-pregnadien-3,20-dioner. | |
| DK116870B (da) | Analogifremgangsmåde til fremstilling af terapeutisk virksomme 11β,21-dihydroxy-3,20-dioxo- eller 21-hydroxy-3,11,20-trioxo-pregna-1,4-dien-(17α 16&alpha,-d)-2'metyloxazoliner eller 21-estere deraf. | |
| DK129835B (da) | Analogifremgangsmåde til fremstilling af 2-chlor-6α-fluor-16α-methyl-pregna-1,4-dien-3,20-dioner. | |
| DK117563B (da) | Analogifremgangsmåde til fremstilling af 17α,21-(1'-alkyl-1'-alkoxy-methylendioxy)-11β-hydroxy-9-α-halogen-16β-methyl-1,4-pregnadien-3,20-dioner. | |
| DK128352B (da) | Analogifremgangsmåde til fremstilling af 9α-fluor-11β-hydroxypregna-1,4-dien-3,20-dion-[17α,16α-d]-oxazolidinoxaziner. | |
| DK130991B (da) | Fremgangsmåde til fremstilling af 16beta-metyl-9alfa-fluor-11beta-17alfa,21-trihydroxy-1,4-pregnadien-3,20-dion eller dets 21-acylater. | |
| DK120190B (da) | Analogifremgangsmåde til fremstilling af terapeutisk aktive 17-estere af 9α,11β-dihalogen-16α-alkyl-Δ<1,4>-pregnadien-17α,21-diol-3,20-dioner. | |
| DK129039B (da) | Fremgangsmåde til fremstilling af 11β,16α17α21-tetrahydroxy-pregna-1,4-dien-3,20-dioner eller de tilsvarende 16,17-acetonider. | |
| DK117894B (da) | Analogifremgangsmåde til fremstilling af 17aα-metyl-17aβ-hydroksy-D-homo-Δ<4,6>-androstadien-3,17-dioner eller deres estere. | |
| DK120337B (da) | Fremgangsmåde til fremstilling af terapeutisk aktive 3-keto-6-halogen-9β10α-Δ<4,6>-steroiddiener af androstan- eller pregnanrækken. | |
| DK131474B (da) | Analogifremgangsmåde til fremstilling af 9alfa-halogen-11beta, 17alfa, 21-trihydroxy-16beta-metylpregna-1,4-dien-3,20-dion-21-adamantan-1'-karboxylater. | |
| DK114690B (da) | Fremgangsmåde til fremstilling af terapeutisk virksomt 17α-ethinyl-Δ<1,3,5(10)>-østratrien-3,16α,17β-triol eller estere eller ethere deraf. | |
| DK120701B (da) | Analogifremgangsmåde til fremstilling af terapeutisk virksomme 17β-tetrahydropyranylethere af Δ<1,3,5(10)>-østratrien-3-ol-eller 3-ethere eller 3-estere deraf. | |
| DK126111B (da) | Fremgangsmåde til fremstilling af Δ<5,10>-steroider med cyclopentanoperhydrophenanthrenstruktur. | |
| DK118557B (da) | Fremgangsmåde til fremstilling af 17α-acyloxy-11β-hydroxy-Δ<4>-pregnen-3,20-dioner. | |
| DK114060B (da) | Fremgangsmåde til fremstilling af terapeutisk virksomme 1,2β-metylensteroider af androstan- eller 9-norandrostanrækken. | |
| DK112235B (da) | Fremgangsmåde til fremstilling af terapeutisk virksomme 21-dicyclohexylmethylcarbonater af 21-hydroxy-Δ<4>-pregnen-17α-ol-3,20-dioner. | |
| DK122453B (da) | Analogifremgangsmåde til fremstilling af 21-estere af 6α,9α-dihalogen-16α-methyl-Δ<1,4>-pregnadien-11β,21-diol-3,20-dioner. | |
| DK113146B (da) | Fremgangsmåde til fremstilling af terapeutisk virksomme 6-halogen-1α,2α-methylen-16α-methyl-&Delta<4,6>-pregnadien-17α-ol-3,20-dioner eller deres 17-estere. | |
| DK127924B (da) | Analogifremgangsmåde til fremstilling af 7α-methyl-3,16α,17β-trihydroxy-Δ1,3,5(10)-estratrien. | |
| DK118556B (da) | Analogifremgangsmåde til fremstilling af 16α-methyl-9α-chlor-Δ<1,4>-pregnadien-11β,21-diol-3,20-dioner eller 21-estere deraf. | |
| DK120746B (da) | Analogifremgangsmåde til fremstilling af 4-klor-1,2α-metylen-Δ<4,6>-pregnadien-17α-ol-3,20-dion eller 17-estere deraf. | |
| DK105065C (da) | Fremgangsmåde til fremstilling af 16α,17α-acetaler eller -ketaler af 3-oxo-16α,17α-dihydroxy-19-nor-4-pregnener eller 3-oxo-16α,17α-dihydroxy-19-nor-5(10)-pregnener. | |
| DK130646B (da) | Analogifremgangsmåde til fremstilling af 17- og/eller 21-alkanoyloxy-11beta-klor-16beta-metylpregna-1,4-dien-3,20-dioner. | |
| DK111615B (da) | Fremgangsmåde til fremstilling af 6α,9α-difluor-16α-metyl-Δ<1,4>-pregnadien-11β,21-diol-3,20-dion eller estere deraf. |